Congressional Leaders To Consider “Emergency Legislation” In Wake Of Heparin Safety Scare
This article was originally published in PharmAsia News
Executive Summary
Congressional leaders have ratcheted up the heat on U.S. FDA and Baxter Healthcare over their handling of the heparin safety scare, alleging that the agency has abandoned its policy to conduct preapproval inspections of API suppliers and saying they would consider introducing "emergency legislation" to mandate such inspections
You may also be interested in...
FDA Supply Chain Initiative And Foreign Inspection Increases Funded Under White House ’10 Budget
The $3.2 billion U.S. FDA budget proposed May 7 by the Obama administration includes a number of proposals aimed at ensuring global drug safety, including a $166 million initiative for improving supply chain safety for medical products
FDA Supply Chain Initiative And Foreign Inspection Increases Funded Under White House ’10 Budget
The $3.2 billion U.S. FDA budget proposed May 7 by the Obama administration includes a number of proposals aimed at ensuring global drug safety, including a $166 million initiative for improving supply chain safety for medical products
HHS Secretary Leavitt Calls For “Explicit Extraterritorial Jurisdiction” For U.S. FDA
U.S. Health and Human Services Secretary Michael Leavitt requested Congress in a Feb. 22 letter to grant FDA "explicit extraterritorial jurisdiction" to investigate manufacturers whose products are subject to the Federal Food, Drug, and Cosmetic Act